Literature DB >> 29669837

Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T Cells.

Hadi Karimzadeh1,2, Muthamia M Kiraithe3, Anna D Kosinska1,4, Manuel Glaser5, Melanie Fiedler2, Valerie Oberhardt3, Elahe Salimi Alizei3, Maike Hofmann3, Juk Yee Mok6, Melanie Nguyen6, Wim J E van Esch6, Bettina Budeus7, Jan Grabowski4,8, Maria Homs9, Antonella Olivero10, Hossein Keyvani11, Francisco Rodríguez-Frías9, David Tabernero9, Maria Buti9, Andreas Heinold12, Seyed Moayed Alavian13, Tanja Bauer1,4, Julian Schulze Zur Wiesch14, Bijan Raziorrouh15, Daniel Hoffmann7, Antonina Smedile10, Mario Rizzetto10, Heiner Wedemeyer4,8, Jörg Timm16, Iris Antes5, Christoph Neumann-Haefelin3, Ulrike Protzer1,4, Michael Roggendorf17,2,4.   

Abstract

Virus-specific CD8 T cell response seems to play a significant role in the outcome of hepatitis delta virus (HDV) infection. However, the HDV-specific T cell epitope repertoire and mechanisms of CD8 T cell failure in HDV infection have been poorly characterized. We therefore aimed to characterize HDV-specific CD8 T cell epitopes and the impacts of viral mutations on immune escape. In this study, we predicted peptide epitopes binding the most frequent human leukocyte antigen (HLA) types and assessed their HLA binding capacities. These epitopes were characterized in HDV-infected patients by intracellular gamma interferon (IFN-γ) staining. Sequence analysis of large hepatitis delta antigen (L-HDAg) and HLA typing were performed in 104 patients. The impacts of substitutions within epitopes on the CD8 T cell response were evaluated experimentally and by in silico studies. We identified two HLA-B*27-restricted CD8 T cell epitopes within L-HDAg. These novel epitopes are located in a relatively conserved region of L-HDAg. However, we detected molecular footprints within the epitopes in HLA-B*27-positive patients with chronic HDV infections. The variant peptides were not cross-recognized in HLA-B*27-positive patients with resolved HDV infections, indicating that the substitutions represent viral escape mutations. Molecular modeling of HLA-B*27 complexes with the L-HDAg epitope and its potential viral escape mutations indicated that the structural and electrostatic properties of the bound peptides differ considerably at the T cell receptor interface, which provides a possible molecular explanation for the escape mechanism. This viral escape from the HLA-B*27-restricted CD8 T cell response correlates with a chronic outcome of hepatitis D infection. T cell failure resulting from immune escape may contribute to the high chronicity rate in HDV infection.IMPORTANCE Hepatitis delta virus (HDV) causes severe chronic hepatitis, which affects 20 million people worldwide. Only a small number of patients are able to clear the virus, possibly mediated by a virus-specific T cell response. Here, we performed a systematic screen to define CD8 epitopes and investigated the role of CD8 T cells in the outcome of hepatitis delta and how they fail to eliminate HDV. Overall the number of epitopes identified was very low compared to other hepatotropic viruses. We identified, two HLA-B*27-restricted epitopes in patients with resolved infections. In HLA-B*27-positive patients with chronic HDV infections, however, we detected escape mutations within these identified epitopes that could lead to viral evasion of immune responses. These findings support evidence showing that HLA-B*27 is important for virus-specific CD8 T cell responses, similar to other viral infections. These results have implications for the clinical prognosis of HDV infection and for vaccine development.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  cytotoxic T lymphocyte; epitope mapping; immune escape; immune selection; large hepatitis delta antigen

Mesh:

Substances:

Year:  2018        PMID: 29669837      PMCID: PMC6002722          DOI: 10.1128/JVI.01891-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald.

Authors:  Romelia Salomon-Ferrer; Andreas W Götz; Duncan Poole; Scott Le Grand; Ross C Walker
Journal:  J Chem Theory Comput       Date:  2013-08-20       Impact factor: 6.006

3.  Generation of peptide-MHC class I complexes through UV-mediated ligand exchange.

Authors:  Boris Rodenko; Mireille Toebes; Sine Reker Hadrup; Wim J E van Esch; Annemieke M Molenaar; Ton N M Schumacher; Huib Ovaa
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Automated benchmarking of peptide-MHC class I binding predictions.

Authors:  Thomas Trolle; Imir G Metushi; Jason A Greenbaum; Yohan Kim; John Sidney; Ole Lund; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Bioinformatics       Date:  2015-02-25       Impact factor: 6.937

5.  Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.

Authors:  D K Wong; D D Dudley; N H Afdhal; J Dienstag; C M Rice; L Wang; M Houghton; B D Walker; M J Koziel
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

6.  Deleterious effects of hepatitis delta virus replication on host cell proliferation.

Authors:  D Wang; J Pearlberg; Y T Liu; D Ganem
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.

Authors:  Kristin Ladell; Masao Hashimoto; Maria Candela Iglesias; Pascal G Wilmann; James E McLaren; Stéphanie Gras; Takayuki Chikata; Nozomi Kuse; Solène Fastenackels; Emma Gostick; John S Bridgeman; Vanessa Venturi; Zaïna Aït Arkoub; Henri Agut; David J van Bockel; Jorge R Almeida; Daniel C Douek; Laurence Meyer; Alain Venet; Masafumi Takiguchi; Jamie Rossjohn; David A Price; Victor Appay
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

8.  Improved side-chain torsion potentials for the Amber ff99SB protein force field.

Authors:  Kresten Lindorff-Larsen; Stefano Piana; Kim Palmo; Paul Maragakis; John L Klepeis; Ron O Dror; David E Shaw
Journal:  Proteins       Date:  2010-06

9.  Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection.

Authors:  Karen Fitzmaurice; Danijela Petrovic; Narayan Ramamurthy; Ruth Simmons; Shazma Merani; Silvana Gaudieri; Stuart Sims; Eugene Dempsey; Elizabeth Freitas; Susan Lea; Susan McKiernan; Suzanne Norris; Aideen Long; Dermot Kelleher; Paul Klenerman
Journal:  Gut       Date:  2011-05-06       Impact factor: 23.059

10.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.

Authors:  Claus Lundegaard; Kasper Lamberth; Mikkel Harndahl; Søren Buus; Ole Lund; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2008-05-07       Impact factor: 16.971

View more
  8 in total

1.  Hepatitis D Virus-Specific CD8+ T Cells Have a Memory-Like Phenotype Associated With Viral Immune Escape in Patients With Chronic Hepatitis D Virus Infection.

Authors:  Helenie Kefalakes; Christopher Koh; John Sidney; Georgios Amanakis; Alessandro Sette; Theo Heller; Barbara Rehermann
Journal:  Gastroenterology       Date:  2019-01-18       Impact factor: 22.682

Review 2.  HDV Pathogenesis: Unravelling Ariadne's Thread.

Authors:  Eirini D Tseligka; Sophie Clément; Francesco Negro
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 3.  Innate immune recognition and modulation in hepatitis D virus infection.

Authors:  Stephanie Jung; Sebastian Maximilian Altstetter; Ulrike Protzer
Journal:  World J Gastroenterol       Date:  2020-06-07       Impact factor: 5.742

4.  Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.

Authors:  Monique T A de Beijer; Diahann T S L Jansen; Yingying Dou; Wim J E van Esch; Juk Yee Mok; Mariëlle J P Maas; Giso Brasser; Robert A de Man; Andrea M Woltman; Sonja I Buschow
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

Review 5.  Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection.

Authors:  Valerie Oberhardt; Maike Hofmann; Robert Thimme; Christoph Neumann-Haefelin
Journal:  Viruses       Date:  2022-01-20       Impact factor: 5.048

Review 6.  Human hepatitis D virus-specific T cell epitopes.

Authors:  Matin Kohsar; Johanna Landahl; Christoph Neumann-Haefelin; Julian Schulze Zur Wiesch
Journal:  JHEP Rep       Date:  2021-04-23

Review 7.  Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition.

Authors:  Maura Dandri; Antonio Bertoletti; Marc Lütgehetmann
Journal:  Semin Immunopathol       Date:  2021-05-21       Impact factor: 9.623

Review 8.  Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease.

Authors:  Stephan Urban; Christoph Neumann-Haefelin; Pietro Lampertico
Journal:  Gut       Date:  2021-06-08       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.